Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication

Published in Viuses 2022, 14(5), 912

Authors: Murray, Bergerson, Jones, Reener, Martin, Sancilio and Tripp

Summary: Dr. Ralph Tripp of the Department of Infectious Diseases, University of Georgia, Athens and his colleagues combined forces with Sancilio and their associates to form a new company called TrippBio, Inc. Utilizing the business expertise of a co-founder, Mr. Billy Meadow, the company began research relevant to the issue of the day: the global triple virus pandemic.